Namuag, Ariel .
HRN: 11-22-81 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/09/2025
METRONIDAZOLE 500MG (TAB)
05/09/2025
05/16/2025
PO
1 1/2 Tab
Tid
Amoebiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes